Deal-making in the Middle East’s life-sciences sector is entering a new phase of expansion as Gulf countries intensify efforts to develop local biologics manufacturing, strengthen health-technology capabilities, and secure long-term strategic capacity through acquisitions and partnerships. A recent industry study indicates that the region has reached a pivotal moment for mergers and acquisitions, driven by major government strategies focused on technology transfer, contract development, manufacturing scale, and sourcing essential medical inputs.
These initiatives align closely with national transformation plans such as Saudi Vision 2030 and the UAE’s Life Sciences Strategy, both of which aim to build resilient supply chains for advanced therapies, biosimilars, and cell-based treatments.
Strong Market Growth Ahead
According to the study, the Middle East’s healthcare Contract Development & Manufacturing Organisation (CDMO) market was valued at $6.27 billion in 2024 and is projected to reach $11.91 billion by 2033, reflecting a steady annual growth rate of 7.5%. Bioprocessing activity—both large and small scale—is also on track to more than double, rising from $1.16 billion in 2024 to $2.44 billion by 2033.
Swayam Dash, Managing Director at Grand View Research, emphasized that the GCC sits at the intersection of scientific capability, investment capital, and forward-leaning government policy. This combination, he noted, is fueling a surge in acquisitions and joint ventures. “Localisation is not just about reducing costs. It is about building a full ecosystem for advanced therapies that can serve the region and eventually scale on a global level,” he said.
Biologics Driving Consolidation
Biologics, biosimilars, and cell-based therapies are receiving growing interest from both investors and government decision-makers. Gulf governments are increasingly focused on reducing dependence on imported treatments by developing domestic therapeutic production lines.
This trend is drawing global pharmaceutical players toward regional partnerships and M&A opportunities. The cell-therapy raw materials segment stands out as one of the fastest-expanding categories, with the market projected to jump from $39.2 million in 2024 to $169.8 million by 2033—a remarkable 17.8% CAGR, representing nearly fourfold growth in less than ten years.
Dubai’s Expanding Role
The study repeatedly highlights Dubai as one of the region’s most important platforms for cross-border manufacturing, research collaboration, and health-technology development. Free-zone regulations, strong logistics connectivity across Europe, Asia, and Africa, and a rising pipeline of digital-health initiatives all contribute to Dubai’s strategic position.
“Dubai is emerging as a central node for life-sciences supply chains—from clinical trials to small-batch biologics manufacturing,” Dash explained. “Its incentives and global talent access make it a natural hub for regional partnerships and consolidation efforts.”
Key Challenges: Talent and Regulation
Despite the strong outlook, the report notes that inconsistent regulatory frameworks and shortages of skilled biotech professionals could influence the speed of large, multi-country transactions. These factors may temporarily slow deal activity, particularly for complex cross-border projects.
However, Dash underscored the long-term ambition of the region. “The Middle East aims not only to purchase advanced therapies—it wants to produce them. Achieving that vision requires consolidation, capability building, and long-term collaboration.”
With growing M&A budgets and a clear focus on localisation, the next two years are expected to shape the first wave of major leaders in the region’s evolving life-sciences manufacturing landscape.
Saad Farooq brings a blend of engineering prowess and a passion for writing to technewsme.com. As a tech engineer based in the vibrant tech landscape of the UAE, Saad has immersed himself in the latest technological advancements, making him an invaluable asset to our team. His deep understanding of tech intricacies comes from hands-on experience in the field, coupled with a genuine love for all things tech.
In his role at technewsme.com, Saad specializes in demystifying complex tech subjects, making them accessible and engaging for our readers. His articles are a reflection of his life in the UAE, a hub of technological innovation, offering a unique perspective on global tech trends and local developments. Whether it’s exploring new tech gadgets, delving into software innovations, or analyzing tech market trends, Saad’s writing is fueled by his extensive engineering background and his enthusiasm for sharing knowledge. Join him on a journey of discovery and insight into the world of technology, right from the heart of the UAE.
